Anti-Human CD194 (CCR4) (Mogamulizumab)Anti-Human CD194 (CCR4) (Mogamulizumab)
Move your mouse over image or click to enlarge

Anti-Human CD194 (CCR4) (Mogamulizumab)

Clone KW-0761 (Mogamulizumab) is a research-grade, afucosylated, humanized monoclonal antibody generated from mouse anti-CCR4 mAb7 that targets human CCR4.1 CC chemokine receptor type 4 (CCR4) is a protein that belongs to the G protein-coupled receptor family and is a receptor for a variety of CC chemokines including MCP-1, MIP-1, RANTES, TARC, and Macrophage-derived chemokine. Chemokines are involved in the development, homeostasis, and function of the immune system and are known to regulate cell trafficking of various types of leukocytes. In a 2018 Phase I clinical trial, Mogamulizumab was found to decrease the number of HTLV-1–infected cells and the levels of inflammatory markers related to HTLV-1–Associated Myelopathy.3
Cat# Size Price Qty Buy
LT1000-100mg 100 mg
£4,781.25
LT1000-50mg 50 mg
£3,515.63
LT1000-25mg 25 mg
£2,296.88
LT1000-5.0mg 5.0 mg
£609.38
LT1000-1.0mg 1.0 mg
£164.06

Additional Information

Property Value or Rating
Manufacturer Cat# LT1000
Concentration ≥ 5.0 mg/ml
Formulation This biosimilar antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Manufacturer Leinco Technologies Inc
Isotype IgG1 κ
Clone KW-0761
Applications Depletion, ELISA, FA, FC
Antigen CCR4 is primarily expressed by Th2 and regulatory T cells in addition to expression on leukemic cells in cutaneous T-cell lymphoma (CTCL).
Storage Functional grade biosimilar antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Protein CD194

Related Documents